Matthias Dobbelstein researcher
Dobbelstein, Matthias
VIAF ID: 9813161763145822560007 (Personal)
Permalink: http://viaf.org/viaf/9813161763145822560007
Preferred Forms
- 100 1 _ ‡a Dobbelstein, Matthias
- 100 0 _ ‡a Matthias Dobbelstein ‡c researcher
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair | |
Activating Ras mutations fail to ensure efficient replication of adenovirus mutants lacking VA-RNA. | |
Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53. | |
Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny | |
The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins | |
Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms | |
Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation. | |
BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways | |
Brdm2 - an aberrant hypomorphic p63 allele | |
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis | |
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication | |
Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death | |
Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity | |
DeltaNp73 can modulate the expression of various genes in a p53-independent fashion | |
Differential regulation of p63 and p73 expression | |
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair | |
Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. | |
Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor | |
Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma | |
E1A genes of adenovirus type 2 and type 5 are expressed at different levels | |
E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. | |
E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection | |
E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis | |
Efficient replication of adenovirus despite the overexpression of active and nondegradable p53. | |
Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice | |
Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins. | |
Exploiting replicative stress to treat cancer | |
Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha. | |
HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer | |
HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates | |
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g. | |
Immunofluorescence-based screening identifies germ cell associated microRNA 302 as an antagonist to p63 expression | |
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment | |
In vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by using randomized and cDNA-derived RNA libraries | |
Inactivation of the p53-homologue p73 by the mdm2-oncoprotein | |
Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A. | |
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression | |
Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin | |
Interchanging heads: p53 re-composes the DREAM/MMB complex to repress transcription | |
Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells | |
A killer promoting survival: p53 as a selective means to avoid side effects of chemotherapy | |
The large T antigen of simian virus 40 binds and inactivates p53 but not p73. | |
The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells | |
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53 | |
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression | |
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors | |
The MDM2 oncoprotein binds specifically to RNA through its RING finger domain | |
Mdm2 - open questions | |
MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP. | |
MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia | |
Mutual interference of adenovirus infection and myc expression | |
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies | |
NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue | |
Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon. | |
Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy | |
The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA. | |
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. | |
Overcoming EMT-driven therapeutic resistance by BH3 mimetics | |
p21/CDKN1A mediates negative regulation of transcription by p53. | |
p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop | |
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest | |
p63 antagonizes Wnt-induced transcription | |
p73 and p63: why do we still need them? | |
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis | |
A polymorphic microsatellite that mediates induction of PIG3 by p53. | |
A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity | |
A promoter that acquired p53 responsiveness during primate evolution | |
Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product | |
Reactivation of mutant p53 by a one-hybrid adaptor protein. | |
Rev protein of human immunodeficiency virus type 1 and cellular exportin 1 protein relocalize each other to a subnucleolar structure | |
Screening analysis of ubiquitin ligases reveals G2E3 as a potential target for chemosensitizing cancer cells | |
Self-association of adenovirus type 5 E1B-55 kDa as well as p53 is essential for their mutual interaction. | |
TAp73 is essential for germ cell adhesion and maturation in testis. | |
Targeting tumour-supportive cellular machineries in anticancer drug development | |
Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart | |
Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain | |
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib | |
Usp22 deficiency impairs intestinal epithelial lineage specification in vivo | |
Viral and cellular factors that target the promyelocytic leukemia oncogenic domains strongly activate a glucocorticoid-responsive promoter | |
Wee1 and Chk1 - crosstalk between key players in replicative stress | |
Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress | |
While p73 is essential, p63 is completely dispensable for the development of the central nervous system | |
YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter |